ARCHIVES

Baltimore Reports On New Method To Aid Leukemia Therapy Design

This article is from The Cancer Letter archive.

Vol. 03 No. 20 | May 20, 1977

Download PDF Visit The Full Archive

Related Articles

Expiring Program Offer Flexibility

February 12, 1982

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

Meta-Analysis Finds ESA Use In Oncology Associated With Increases In VTE, Mortality.

February 29, 2008

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977